Paced respiration for vasomotor and other menopausal symptoms: A randomized, controlled trial

Journal of General Internal Medicine

Volumn 28, Issue 2, 2013, Pages 193-200

  Carpenter, Janet S ^a,c   Burns, Debra S ^a   Wu, Jingwei ^a   Otte, Julie L ^a,c   Schneider, Bryan ^a   Ryker, Kristin ^a,c   Tallman, Eileen ^a,c   Yu, Menggang ^b  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c INDIANA UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

menopausal symptoms; menopause; paced respiration; vasomotor symptoms

Indexed keywords

ADL DISABILITY; ADULT; ADVERSE OUTCOME; ARTICLE; BREAST CANCER; BREATHING EXERCISE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE SEVERITY; FEMALE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MOOD DISORDER; PACED RESPIRATION; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RESPIRATION CONTROL; SINGLE BLIND PROCEDURE; SLEEP DISORDER; TREATMENT DURATION; TREATMENT OUTCOME; VASOMOTOR DISORDER; VIDEO DISK;

ADULT; BREAST NEOPLASMS; BREATHING EXERCISES; FEMALE; HOT FLASHES; HUMANS; MENOPAUSE; MIDDLE AGED; PATIENT COMPLIANCE; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; SLEEP DISORDERS; SURVIVORS; TREATMENT OUTCOME; VASOMOTOR SYSTEM;

EID: 84871566481     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-012-2202-6     Document Type: Article

References (23)

1. Rada G, Capurro D, Pantoja T, Corbalan J, Moreno G, Letelier LM, et al. Non-hormonal interventions for hot flushes in women with a history of breast cancer. Cochrane Database Syst Rev. 2010;(9):CD004923.
2. Stearns V, Johnson MD, Rae JM, Morocho A, Novielli A, Bhargava P, et al. Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin re-uptake inhibitor paroxetine. J Natl Cancer Inst. 2003;95(23):1758-64.
3. North American Menopause Society N. Menopause Practice: a Clinician's Guide. 4th ed. Mayfield Heights: North American Menopause Society; 2010.
4. North American Menopause Society N. The Menopause Guidebook. 7th ed. Mayfield Heights: North American Menopause Society; 2012.
5. Freedman RR, Woodward S. Behavioral treatment of menopausal hot flushes: evaluation by ambulatory monitoring. Am J Obstet Gynecol. 1992;167(2):436-9.
6. Freedman RR, Woodward S, Brown B, Javiad JI, Pandey GN. Biochemical and thermoregulatory effects of behavioral treatment for menopausal hot flashes. Menopause. 1995;2(4):211-8.
7. Germaine LM, Freedman RR. Behavioral treatment of menopausal hot flashes: evaluation by objective methods. J Consult Clin Psychol. 1984;52(6):1072-9.
8. Butt DA, Deng LYR, Lewis JE, Lock M. Minimal decrease in hot flashes desired by postmenopausal women in family practice. Menopause. 2007;14(2):203-7.
9. Carpenter JS, Storniolo AM, Johns S, Monahan PO, Azzouz F, Elam JL, et al. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer. Oncologist. 2007;12(1):124-35.
10. Carson JW, Carson KM, Porter LS, Keefe FJ, Seewaldt VL. Yoga of Awareness program for menopausal symptoms in breast cancer survivors: results from a randomized trial. Support Care Cancer. 2009;17(10):1301-9.
11. Ganz PA, Greendale GA, Petersen L, Zibecchi L, Kahn B, Belin TR. Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. J Natl Cancer Inst. 2000;92(13):1054-64.
12. Mann E, Smith M, Hellier J, Hunter MS. A randomised controlled trial of a cognitive behavioural intervention for women who have menopausal symptoms following breast cancer treatment (MENOS 1): trial protocol. BMC Cancer. 2011;11:44.
13. Carpenter JS, Neal JG, Payne J, Kimmick G, Storniolo AM. Cognitive-behavioral intervention for hot flashes. Oncol Nurs Forum. 2007;34(1):E1-8.
14. Carpenter JS. The Hot Flash Related Daily Interference Scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer. J Pain Symptom Manag. 2001;22(6):979-89.
15. Reynolds F. Relationships between catastrophic thoughts, perceived control and distress during menopausal hot flushes: exploring the correlates of a questionnaire measure. Maturitas. 2000;36(2):113-22.
16. Reynolds FA. Perceived control over menopausal hot flushes: exploring the correlates of a standardised measure. Maturitas. 1997;27(3):215-21.
17. Koller M, Kussman J, Lorenz W, Jenkins M, Voss M, Arens E, et al. Symptom reporting in cancer patients: the role of negative affect and experienced social stigma. Cancer. 1996;77(5):983-95.
18. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988;54(6):1063-70.
19. Curran SL, Andrykowski M, Studts JL. Short form of the Profile of Mood States (POMS-SF): psychometric information. Psychol Assess. 1995;7(1):80-3.
20. McNair DM, Lorr M, Droppelman LF. POMS Manual for the Profile of Mood States. San Diego: Educational and Industrial Testing Service; 1971.
21. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193-213.
22. Taffe J, Dennerstein L. Menstrual diary data and menopausal transition: methodologic issues. Acta Obstet Gynecol Scand. 2002;81(7):588-94.
23. Carpenter JS, Newton KM, Sternfeld B, Joffe H, Reed SD, Ensrud KE, et al. Laboratory and ambulatory evaluation of vasomotor symptom monitors from the Menopause Strategies Finding Lasting Answers for Symptoms and Health network. Menopause. 2012;19(6):664-71.